Antineoplastic Activity of Highly Purified Bacterial Glutaminases

Article metrics

Abstract

SEVERAL lines of evidence motivated the treatment of neoplasms by glutaminase to cause glutamine deprivation. Certain tumour cells grown in tissue culture require glutamine at a level which is tenfold or greater than that of any other amino-acid1,2. Glutamine participates in a wide variety of metabolic reactions in mammalian cells3. It has been suggested that one of the important functions of glutamine in the metabolism of certain tumours may be as a direct precursor of glutamic acid, which can then furnish the carbon for the partial operation of the tricarboxylic acid cycle from α-ketoglutarate to oxaloacetate4. Compared with other tissues, certain tumour cells seem to operate at a marginal level of glutamine availability because of slow synthesis5 and rapid utilization4. The glutamine antagonists, azaserine and 6-diazo-5-oxonorleucine (DON) have been shown to possess moderate antineoplastic activity, which may be enhanced by L-asparaginase6–8. Greenberg et al.9 reported that a glutaminase-asparaginase preparation with a relatively high glutamine Km (7 × 10−3M) decreased the initial rate of growth of a number of tumours, including an Ehrlich ascites carcinoma, but caused no significant increase in the survival time of tumour-bearing animals. In this study, more intensive therapy with three extensively purified glutaminase preparations with considerably lower Km values resulted in marked inhibition of an Ehrlich ascites carcinoma and significant increases in the survival time of tumour-bearing animals.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Eagle, H., Oyama, V. I., Levy, M., Horton, C. L., and Fleishman, R., J. Biol. Chem., 218, 607 (1956).

  2. 2

    Neuman, R. E., and McCoy, T. A., Science, 124, 124 (1956).

  3. 3

    Meister, A., Biochemistry of the Amino-Acids, second ed., 2, 621 (Academic Press, New York, 1965).

  4. 4

    Roberts, E., and Simonsen, D. G., in Amino Acids, Proteins and Cancer Biochemistry (edit. by Edsall, J. T.), 121 (Academic Press, New York, 1960).

  5. 5

    Levintow, L., J. Nat. Cancer Inst., 15, 347 (1954).

  6. 6

    Tarnowski, G. S., Mountain, I. M., and Stock, C. C., Proc. Amer. Assoc. Cancer Res., 10, 92 (1969).

  7. 7

    Mashburn, L. T., Proc. Amer. Assoc. Cancer Res., 9, 45 (1968).

  8. 8

    Jacobs, S. P., Wodinsky, I., Kensler, C. J., and Venditti, J., Proc. Amer. Assoc. Cancer Res., 10, 43 (1969).

  9. 9

    Greenberg, D. M., Blumenthal, G., and Ramadan, M. A., Cancer Res., 24, 957 (1964).

  10. 10

    Roberts, J., Prager, M. D., and Bachynsky, N., Cancer Res., 26, 2213 (1966).

  11. 11

    Dolowy, W. C., Ammeraal, R. N., Cornet, J., and Henson, D., Presbyterian. St. Luke's Hosp. Med. Bull., 6, No. 3 (1967).

  12. 12

    Holcenberg, J. S., Biochim. Biophys. Acta, 185, 228 (1969).

  13. 13

    Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R., J. Biol. Chem., 193, 265 (1951).

  14. 14

    Broome, J. D., Brit. J. Cancer, 22, 595 (1968).

  15. 15

    Sobin, L. H., and Kidd, J. G., Proc. Soc. Exp. Biol. Med., 119, 325 (1965).

  16. 16

    Hayaishi, O., in Methods in Enzymology (edit. by Colowick, S. P., and Kaplan, N. O.), 1, 126 (Academic Press, New York, 1955).

  17. 17

    Roberts, J., Burson, G., and Hill, J. M., J. Bact., 95, 2117 (1968).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

ROBERTS, J., HOLCENBERG, J. & DOLOWY, W. Antineoplastic Activity of Highly Purified Bacterial Glutaminases. Nature 227, 1136–1137 (1970) doi:10.1038/2271136a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.